达沙替尼通过SRC-MAPK通路调节抑制大细胞体中的β冠状病毒复制并减弱促炎媒介
Ana Carolina Santos Ricoy1, Marina Pimenta Braga1, Thaís Targino Ferreira Lacerda1
1Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Medical microbiology and immunology
|August 27, 2025
概括
达沙替尼 (DASA) 通过向巨细胞中的SRC信号来减少贝塔冠状病毒的复制和炎症. 这项研究表明,DASA可作为冠状病毒感染的潜在辅助疗法,影响病毒进入和炎症途径.
科学领域:
- 病毒学
- 免疫学
- 药理学
背景情况:
- 像SARS-CoV-2这样的贝塔冠状病毒通过触发巨细胞的炎症引起严重的疾病.
- 达沙替尼 (DASA) 是一种氨酸激酶抑制剂,在癌症治疗之外也表现出抗炎症和抗病毒作用.
研究的目的:
- 研究达沙替尼 (DASA) 作为对抗贝塔冠状病毒感染的潜在治疗剂.
- 探索DASA对巨细胞病毒复制和炎症反应的影响.
主要方法:
- 在实验室感染模型使用RAW 264.7细胞和MHV-3β冠状病毒.
- 在感染前和感染后使用DASA治疗.
- 测量病毒标位和促炎媒介 (IL-6,TNF,CXCL2).
- 对SRC-MAPK-NF-B信号通路激活的分析.
主要成果:
- DASA治疗显著降低了MHV-3病毒标位和促炎媒介.
- 用DASA进行前期治疗可以抑制病毒早期进入巨细胞.
- DASA调节了SRC氨酸激酶信号,抑制了SRC-MAPK-NF-B通路.
- 感染后的DASA治疗减少了炎症媒介的释放.
结论:
- 达沙替尼 (DASA) 显示出作为治疗贝塔冠状病毒感染的辅助疗法的潜力.
- 通过向SRC介导的信号通路,DASA有效地减少病毒复制和炎症.
- 针对SRC信号提供了控制冠状病毒感染的可行策略.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K


